-
平臺編號：bio-50124
-
國際編號：ATCC VR-3157
-
拉丁屬名： Vaccinia virus ts mutant
-
規(guī)格：frozen
-
用途：ATCC原裝進口
-
服務費用：
加載中…… - 訂購
-
注意事項：僅用于科學研究或者工業(yè)應用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準）
中文名稱暫無
ATCC? Number:VR-3157?
Classification: Poxviridae, Orthopoxvirus
Agent: Vaccinia virus ts mutant
Strain: IHD-W Dts86
Depositors: S. Dales, R. Condit
Biosafety Level:2
Shipped: frozen
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Host Organism : Production host: BSC-40 (ATCCCRL-2761)Alternate hosts: MRC-5, BSC-1, HeLa, LLC-MK2
Incubation : For best results, plate cells 24-48 hours in advance in DMEM with 10% FBS at 37.0°C. Infect at 90-100% confluence using a multiplicity of infection (MOI) of about 1. Infect and incubate in DMEM supplemented with 2% FBS at 32.0°C for 1-3 days. Harvest cells and culture fluids when 100% of culture shows advanced cytopathic effects. Vaccinia virus is largely cell associated. Concentrated preparations can be made by collection and sonication of cell pellets.
Effect : Cytopathic effects in culture include enlargement and rounding of cells, followed by death and sloughing.
Store at : -70.0°C or colder
Comments : This conditional lethal mutant, originally designated plaque isolate number 9179, was isolated from the IHD-W strain of Vaccinia by S. Dales. The IHD-W strain was derived from an IHD-J strain. This mutant was selected after mutagenesis with nitrosoguanidine and replication in the presence of bromodeoxyuridine. This mutant was not assigned to a Dales EM category. The mutation was assigned by complementation analysis (Lackner, et al, 2003) to vaccinia map location A24, the 132-kDa RNA polymerase subunit. The non-permissive incubation temperature is 39.5°C. Vaccination is recommended for laboratory staff manipulating vaccinia, monkeypox, and cowpox viruses.
Related Products: Virus: ATCC VR-1441
Classification: Poxviridae, Orthopoxvirus
Agent: Vaccinia virus ts mutant
Strain: IHD-W Dts86
Depositors: S. Dales, R. Condit
Biosafety Level:2
Shipped: frozen
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Host Organism : Production host: BSC-40 (ATCCCRL-2761)Alternate hosts: MRC-5, BSC-1, HeLa, LLC-MK2
Incubation : For best results, plate cells 24-48 hours in advance in DMEM with 10% FBS at 37.0°C. Infect at 90-100% confluence using a multiplicity of infection (MOI) of about 1. Infect and incubate in DMEM supplemented with 2% FBS at 32.0°C for 1-3 days. Harvest cells and culture fluids when 100% of culture shows advanced cytopathic effects. Vaccinia virus is largely cell associated. Concentrated preparations can be made by collection and sonication of cell pellets.
Effect : Cytopathic effects in culture include enlargement and rounding of cells, followed by death and sloughing.
Store at : -70.0°C or colder
Comments : This conditional lethal mutant, originally designated plaque isolate number 9179, was isolated from the IHD-W strain of Vaccinia by S. Dales. The IHD-W strain was derived from an IHD-J strain. This mutant was selected after mutagenesis with nitrosoguanidine and replication in the presence of bromodeoxyuridine. This mutant was not assigned to a Dales EM category. The mutation was assigned by complementation analysis (Lackner, et al, 2003) to vaccinia map location A24, the 132-kDa RNA polymerase subunit. The non-permissive incubation temperature is 39.5°C. Vaccination is recommended for laboratory staff manipulating vaccinia, monkeypox, and cowpox viruses.
Related Products: Virus: ATCC VR-1441
